A favorable review of exercise does not establish which program works best, or that short-term craving reductions produce lasting abstinence. A 2024 systematic review brought together research on mood, cognition and craving in methamphetamine use disorder. Its findings support further study of exercise as an intervention, while leaving important questions about comparative benefit, durability and mechanism unresolved.
The central interpretive issue is what was synthesized. The review describes varied studies rather than reporting a pooled effect estimate that can rank treadmill exercise, tai chi, resistance training, cycling and dance.
What research did the review include?
Xu and colleagues searched PubMed and Embase for English-language articles from 2014 through October 2023. Published on May 17, 2024, the review included 17 studies from 133 retrieved records and reported a total of 1,836 participants. That is the review’s aggregate reported sample, not one randomized trial of 1,836 people.
Eligible studies involved people with methamphetamine use disorder, clearly described physical activity and quantifiable outcomes addressing negative mood, cognition or drug craving. Prospective studies, randomized trials and intervention studies were eligible. The authors describe most included studies as randomized controlled designs.
The review did not administer methamphetamine or establish an acute dose–response relationship. Its clinical question concerned exercise interventions in people with an existing disorder. Historical use, withdrawal and rehabilitation context are different from experimentally controlled intoxication.
Why is “exercise” not a single exposure?
The included programs differed in activity, intensity, session length, frequency and duration. Some examined an acute session lasting minutes. Others used repeated sessions across weeks or months. Comparisons also differed; the discussion describes health-education materials or videos as control conditions.
A brief exercise session and an eight-week training program therefore cannot be treated as identical interventions simply because both involve physical activity. The same applies to participants selected from different rehabilitation settings and to male-only, female-only and mixed samples. A benefit in one context is not automatically the effect expected in another.
The review’s discussion reports individual study sizes ranging from 24 to 466 and participant ages from 18 to 45 years. Those descriptions do not establish uniform representation across ages, sexes, disease severity or treatment settings.
Which outcomes should remain separate?
| Endpoint | What it can describe | What it does not establish by itself |
|---|---|---|
| Mood questionnaire | Reported anxiety, depression or related symptoms under the study conditions | Confirmed drug abstinence or restoration of every cognitive function |
| Craving rating | Experienced desire for methamphetamine, sometimes after a cue or immediately after exercise | Actual subsequent consumption or sustained recovery |
| Stroop or Go/No-Go performance | A particular aspect of responding, attention or inhibition | Global cognitive recovery or safe driving |
| Urine testing and self-reported use | Study-defined drug-use outcomes during their observation windows | Permanent abstinence, a blood concentration or impairment at an unrelated event |
| Physiological or imaging measure | A measured biological difference associated with the intervention | Proof that the proposed biological pathway caused the clinical outcome |
The review describes acute craving assessments during exercise, immediately afterward and approximately 50 minutes later. A difference within that short window cannot establish a benefit persisting for months. Conversely, a longer follow-up study should be evaluated on its own use-related outcomes and denominators, rather than assumed to confirm every short-term craving result.
Does the review show that exercise prevents relapse?
It discusses one study with follow-up at one, three and six months after treatment. The summary table identifies reduced methamphetamine use among lower-severity users following an eight-week treadmill intervention. That qualified description should not become a claim that every exercise program prevented relapse in every severity group.
The review’s broader conclusion is optimistic, but the authors also call for longer-term evaluation of efficacy and sustainability. Its reported synthesis provides no pooled relapse probability, common number needed to treat or validated prediction for an individual patient. A review-level narrative should not be used to manufacture those quantities.
Can it identify the best intensity or exercise type?
The authors describe favorable findings for moderate-intensity activity and high-intensity interval training. They also acknowledge that the effects of different exercise patterns, frequencies and durations are not fully clear. The programs were inconsistent in duration and design.
Finding favorable outcomes in separate trials is not equivalent to a head-to-head randomized comparison of the programs. Differences in baseline severity, comparison conditions, adherence, assessment timing and endpoint selection can influence the apparent pattern. The review does not provide a common quantitative analysis that resolves those differences into a treatment ranking.
Nor does the absence of an established ranking mean all programs have equal effects. It means the evidence summarized here does not settle that comparative question.
Were the proposed mechanisms measured in the included human studies?
Some human studies examined physiological or brain-related measures. The review also discusses animal work involving wheel running, dopamine-related changes and inflammation as potential biological explanations. Its eligibility criteria excluded animal and in-vitro studies from the included clinical evidence, even though animal experiments appear in the explanatory discussion.
That distinction matters. A mechanism observed in an animal model is supporting biological context, not an additional human exercise trial. A human change in receptor binding or a peripheral inflammatory marker also does not, by itself, demonstrate that this change mediated improvement in craving or cognition.
The authors identify the absence of efficient, sensitive and objective biomarkers as an unresolved problem. Their suggestions for future biomarkers should remain research proposals rather than individual diagnostic tests.
How should this review be used?
Use it as a historical map of a heterogeneous clinical literature, with encouraging signals across several outcome categories. Preserve the particular activity, timing, comparator and outcome when discussing any underlying result. The review reports its conclusions narratively and does not supply the precision of a pooled estimate or a validated personalized exercise prescription.
For forensic interpretation, participation in rehabilitation, a lower craving score or improved laboratory inhibition does not establish drug absence, impairment or lack of impairment at a particular time. Those are separate questions requiring case-specific evidence.
Scientific source
Xu C, Zhang Z, Hou D, et al. Effects of exercise interventions on negative emotions, cognitive performance and drug craving in methamphetamine addiction. Frontiers in Psychiatry. 2024;15:1402533. doi:10.3389/fpsyt.2024.1402533. Full-text article. Historical systematic review with narrative synthesis; search coverage through October 2023.
Leave a Reply